- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 112,905 | 31.07.24 20:45:36 | -2,345 | -2,03% | 112,900 | 112,910 | 123,480 | 115,250 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 109,760 | 31.07.24 20:44:26 | -0,350 | -0,32% | 109,320 | 110,200 | 110,320 | 110,110 |
